Jordi Sierra Gil-rekin lankidetzan egindako argitalpenak (10)

2020

  1. Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols

    European Journal of Haematology, Vol. 105, Núm. 2, pp. 138-147

2018

  1. CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+ patients with good prognosis

    PLoS ONE, Vol. 13, Núm. 6

  2. Focal adhesion genes refine the intermediate-risk cytogenetic classification of acute myeloid leukemia

    Cancers, Vol. 10, Núm. 11

2017

  1. NEDD 9 an independent good prognostic factor in intermediaterisk acute myeloid leukemia patients

    Oncotarget, Vol. 8, Núm. 44, pp. 76003-76014

2015

  1. CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia

    Haematologica

  2. CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival

    Journal of Pathology, Vol. 235, Núm. 3, pp. 445-455

2014

  1. Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometry: A bridge to individualized medicine

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 14, Núm. 4, pp. 305-318

2004

  1. HLA-DPB1 mismatch in HLA-A-B-DRB1 identical sibling donor stem cell transplantation and acute graft-versus-host disease

    Transplantation, Vol. 77, Núm. 7, pp. 1107-1110

2003

  1. Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning

    Bone Marrow Transplantation, Vol. 31, Núm. 5, pp. 387-392

2001

  1. Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation

    British Journal of Haematology, Vol. 114, Núm. 4, pp. 931-936